Los fármacos de acción prolongada podrían revolucionar el tratamiento de VIHnews2024-04-21T07:02:00+00:00April 21st, 2024|The New York Times|
Inside Novo Nordisk, the Company Behind Ozempic and Wegovynews2024-04-20T04:01:23+00:00April 20th, 2024|The New York Times|
Long-Acting Drugs May Revolutionize H.I.V. Prevention and Treatmentnews2024-04-17T22:46:45+00:00April 17th, 2024|The New York Times|
Opill, an Over-the-Counter Birth Control Pill, Will Be Available Soonnews2024-03-04T22:59:02+00:00March 4th, 2024|The New York Times|
J&J, Merck and Bristol Myers Squibb CEOs Testify at Senate Hearing on Drug Pricesnews2024-02-08T21:15:51+00:00February 8th, 2024|The New York Times|
Medicare Recipients Can Save on Drugs in 2024news2024-02-04T08:00:46+00:00February 4th, 2024|The New York Times|
6 Reasons That It’s Hard to Get Your Wegovy and Other Weight-Loss Prescriptionsnews2024-02-02T20:20:57+00:00February 2nd, 2024|The New York Times|
U.S. Makes Initial Offers in Medicare Drug Price Negotiationsnews2024-02-01T18:36:19+00:00February 1st, 2024|The New York Times|